These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 28396117

  • 1. The P2X7 receptor antagonist, oxidized adenosine triphosphate, ameliorates renal ischemia-reperfusion injury by expansion of regulatory T cells.
    Koo TY, Lee JG, Yan JJ, Jang JY, Ju KD, Han M, Oh KH, Ahn C, Yang J.
    Kidney Int; 2017 Aug; 92(2):415-431. PubMed ID: 28396117
    [Abstract] [Full Text] [Related]

  • 2. P2X7 receptor signaling promotes inflammation in renal parenchymal cells suffering from ischemia-reperfusion injury.
    Qian Y, Qian C, Xie K, Fan Q, Yan Y, Lu R, Wang L, Zhang M, Wang Q, Mou S, Dai H, Ni Z, Pang H, Gu L.
    Cell Death Dis; 2021 Jan 27; 12(1):132. PubMed ID: 33504771
    [Abstract] [Full Text] [Related]

  • 3. P2X7 receptor inhibition protects against ischemic acute kidney injury in mice.
    Yan Y, Bai J, Zhou X, Tang J, Jiang C, Tolbert E, Bayliss G, Gong R, Zhao TC, Zhuang S.
    Am J Physiol Cell Physiol; 2015 Mar 15; 308(6):C463-72. PubMed ID: 25588875
    [Abstract] [Full Text] [Related]

  • 4. ATP induces PAD4 in renal proximal tubule cells via P2X7 receptor activation to exacerbate ischemic AKI.
    Rabadi M, Kim M, Li H, Han SJ, Choi Y, D'Agati V, Lee HT.
    Am J Physiol Renal Physiol; 2018 Feb 01; 314(2):F293-F305. PubMed ID: 29021225
    [Abstract] [Full Text] [Related]

  • 5. Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection.
    Vergani A, Fotino C, D'Addio F, Tezza S, Podetta M, Gatti F, Chin M, Bassi R, Molano RD, Corradi D, Gatti R, Ferrero ME, Secchi A, Grassi F, Ricordi C, Sayegh MH, Maffi P, Pileggi A, Fiorina P.
    Diabetes; 2013 May 01; 62(5):1665-75. PubMed ID: 23315496
    [Abstract] [Full Text] [Related]

  • 6. IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells.
    Kim MG, Koo TY, Yan JJ, Lee E, Han KH, Jeong JC, Ro H, Kim BS, Jo SK, Oh KH, Surh CD, Ahn C, Yang J.
    J Am Soc Nephrol; 2013 Oct 01; 24(10):1529-36. PubMed ID: 23833258
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X Axis.
    Gazzerro E, Baldassari S, Assereto S, Fruscione F, Pistorio A, Panicucci C, Volpi S, Perruzza L, Fiorillo C, Minetti C, Traggiai E, Grassi F, Bruno C.
    Am J Pathol; 2015 Dec 01; 185(12):3349-60. PubMed ID: 26465071
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin type 2 receptor activation limits kidney injury during the early phase and induces Treg cells during the late phase of renal ischemia.
    Ali R, Patel S, Hussain T.
    Am J Physiol Renal Physiol; 2021 May 01; 320(5):F814-F825. PubMed ID: 33719572
    [Abstract] [Full Text] [Related]

  • 9. Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage.
    Safya H, Mellouk A, Legrand J, Le Gall SM, Benbijja M, Kanellopoulos-Langevin C, Kanellopoulos JM, Bobé P.
    Front Immunol; 2018 May 01; 9():360. PubMed ID: 29535730
    [Abstract] [Full Text] [Related]

  • 10. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury.
    Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, Ju ST, Okusa MD.
    J Am Soc Nephrol; 2009 Aug 01; 20(8):1744-53. PubMed ID: 19497969
    [Abstract] [Full Text] [Related]

  • 11. IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal Injury.
    Stremska ME, Jose S, Sabapathy V, Huang L, Bajwa A, Kinsey GR, Sharma PR, Mohammad S, Rosin DL, Okusa MD, Sharma R.
    J Am Soc Nephrol; 2017 Sep 01; 28(9):2681-2693. PubMed ID: 28539382
    [Abstract] [Full Text] [Related]

  • 12. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma.
    Day YJ, Huang L, Ye H, Li L, Linden J, Okusa MD.
    J Immunol; 2006 Mar 01; 176(5):3108-14. PubMed ID: 16493070
    [Abstract] [Full Text] [Related]

  • 13. P2X7 receptor blockade protects against cisplatin-induced nephrotoxicity in mice by decreasing the activities of inflammasome components, oxidative stress and caspase-3.
    Zhang Y, Yuan F, Cao X, Zhai Z, GangHuang, Du X, Wang Y, Zhang J, Huang Y, Zhao J, Hou W.
    Toxicol Appl Pharmacol; 2014 Nov 15; 281(1):1-10. PubMed ID: 25308879
    [Abstract] [Full Text] [Related]

  • 14. Protective Effect of CXCR3⁺CD4⁺CD25⁺Foxp3⁺ Regulatory T Cells in Renal Ischemia-Reperfusion Injury.
    Jun C, Qingshu L, Ke W, Ping L, Jun D, Jie L, Su M.
    Mediators Inflamm; 2015 Nov 15; 2015():360973. PubMed ID: 26273136
    [Abstract] [Full Text] [Related]

  • 15. Granulocyte Colony-Stimulating Factor Attenuates Renal Ischemia-Reperfusion Injury by Inducing Myeloid-Derived Suppressor Cells.
    Yan JJ, Ryu JH, Piao H, Hwang JH, Han D, Lee SK, Jang JY, Lee J, Koo TY, Yang J.
    J Am Soc Nephrol; 2020 Apr 15; 31(4):731-746. PubMed ID: 32132198
    [Abstract] [Full Text] [Related]

  • 16. The Differential Effect of Apyrase Treatment and hCD39 Overexpression on Chronic Renal Fibrosis After Ischemia-Reperfusion Injury.
    Roberts V, Campbell DJ, Lu B, Chia J, Cowan PJ, Dwyer KM.
    Transplantation; 2017 Jul 15; 101(7):e194-e204. PubMed ID: 28198766
    [Abstract] [Full Text] [Related]

  • 17. Peritubular capillary preservation with COMP-angiopoietin-1 decreases ischemia-reperfusion-induced acute kidney injury.
    Jung YJ, Kim DH, Lee AS, Lee S, Kang KP, Lee SY, Jang KY, Sung MJ, Park SK, Kim W.
    Am J Physiol Renal Physiol; 2009 Oct 15; 297(4):F952-60. PubMed ID: 19656917
    [Abstract] [Full Text] [Related]

  • 18. mTOR Signaling Regulates Protective Activity of Transferred CD4+Foxp3+ T Cells in Repair of Acute Kidney Injury.
    Chen G, Dong Z, Liu H, Liu Y, Duan S, Liu Y, Liu F, Chen H.
    J Immunol; 2016 Nov 15; 197(10):3917-3926. PubMed ID: 27798166
    [Abstract] [Full Text] [Related]

  • 19. Both PD-1 ligands protect the kidney from ischemia reperfusion injury.
    Jaworska K, Ratajczak J, Huang L, Whalen K, Yang M, Stevens BK, Kinsey GR.
    J Immunol; 2015 Jan 01; 194(1):325-33. PubMed ID: 25404361
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of the purinergic pathway prolongs mouse lung allograft survival.
    Liu K, Vergani A, Zhao P, Ben Nasr M, Wu X, Iken K, Jiang D, Su X, Fotino C, Fiorina P, Visner GA.
    Am J Respir Cell Mol Biol; 2014 Aug 01; 51(2):300-10. PubMed ID: 24661183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.